NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹4,327 Cr | ₹3,051 Cr | ₹2,317 Cr | ₹1,776 Cr | ₹1,819 Cr |
What is the latest Net Current Assets ratio of NATCO PHARMA ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹4,327 Cr |
| Mar2024 | ₹3,051 Cr |
| Mar2023 | ₹2,317 Cr |
| Mar2022 | ₹1,776 Cr |
| Mar2021 | ₹1,819 Cr |
How is Net Current Assets of NATCO PHARMA Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹4,327 Cr | 41.82 | |
| Mar2024 | ₹3,051 Cr | 31.65 | |
| Mar2023 | ₹2,317 Cr | 30.45 | |
| Mar2022 | ₹1,776 Cr | -2.36 | |
| Mar2021 | ₹1,819 Cr | - | |
Compare Net Current Assets of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹15,992.7 Cr | 3.9% | -24.6% | -1.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,148.0 Cr | 3.5% | -1.5% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,009.0 Cr | 1.1% | -1.1% | 0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,779.0 Cr | -0.2% | -0.3% | 35% | Stock Analytics | |
| CIPLA | ₹115,772.0 Cr | 3.1% | 1% | -11.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,616.0 Cr | 1.1% | -2.1% | -5.6% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | 3.9% |
-24.6% |
-1.6% |
| SENSEX | -0.8% |
1.4% |
-6.8% |
You may also like the below Video Courses